UPB - Upstream Bio, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$33.00
DETAILS
HIGH:
$51.00
LOW:
$15.00
MEDIAN:
$33.00
CONSENSUS:
$33.00
UPSIDE:
294.27%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 100.0% |
| EBIT Margin | -5618.8% |
| EBITDA Margin | -5612.2% |
| Operating Margin | -5618.8% |
| Pretax Margin | -5026.0% |
| Cont. Ops Margin | -5026.0% |
| Net Margin | -5026.0% |
| Bottom Line Margin | -5026.0% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 26.15 |
| Quick Ratio | 26.15 |
| Solvency Ratio | -10.232 |
| Cash Ratio | 7.55 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings |
-10.19
Peers avg: 9.5
|
| PEG Ratio | -0.13 |
| Forward PEG | -0.13 |
| Price/Book | 4.30 |
| Price/Sales | 512.30 |
| Price/FCF | -10.97 |
| Price/Op Cash Flow | -10.97 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0036 |
| Debt/Equity | 0.0037 |
| Debt/Capital | 0.0037 |
| Long-Term Debt/Capital | 0.0016 |
| Financial Leverage | 1.04 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.01 |
| Operating Cash Flow Ratio | -9.907 |
| Operating Cash Flow/Sales | -4669.8% |
| Free Cash Flow/Operating Cash Flow | 100.0% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -222.46 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -185.10 |
| Operating Cash Flow Coverage | -105.02 |
| Capital Expenditure Coverage | -807.73 |
| Dividend + Capital Expenditure Coverage | -807.73 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.05 |
| EPS | -2.664 |
| Debt/Share | 0.0236 |
| Cash/Share | 6.34 |
| Book Value/Share | 6.31 |
| Tangible BV/Share | 6.31 |
| Equity/Share | 6.31 |
| Operating Cash Flow/Share | -2.475 |
| Capital Expenditure/Share | 0.003 |
| FCF/Share | -2.475 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.000 |
| Earnings Before Tax/EBIT | 0.895 |
| Price/Fair Value | 4.30 |
| Debt/Market Cap | 0.0009 |
| Effective Tax Rate | 0.0% |
| Enterprise Value Multiple | -8.50 |